Functional shotgun metagenomic insights into gut microbial pathway and enzyme disruptions linking metabolism, affect, cognition, and suicidal ideation in major depressive disorder.

Gut microbiome alpha diversity (species richness and evenness) was similar between MDD patients and controls.

• Both species richness and evenness metrics showed no significant differences between MDD and control groups.
• This finding suggests that overall diversity metrics alone are insufficient to characterize gut dysbiosis in MDD.
• Taxonomic profiling was performed using MetaPhlAn v4.0.6 on shotgun metagenomic data.

The top enriched taxa in the multivariate discriminant profile of MDD were Ruminococcus gnavus, Veillonella rogosaem, and Anaerobutyricum hallii, reflecting gut dysbiosis associated with leaky gut and NIMETOX mechanisms.

• These three taxa were identified as the top enriched organisms in MDD patients compared to controls.
• These taxa are associated with leaky gut and neuro-immune, metabolic, and oxidative stress (NIMETOX) mechanisms.
• Ruminococcus gnavus is known in the literature to be associated with increased intestinal permeability.
• Multivariate discriminant analysis was used to identify the profile distinguishing MDD from controls.

The top four protective taxa enriched in controls were Vescimonas coprocola, Coprococcus, Faecalibacterium prausnitzii, and Faecalibacterium parasitized, indicating an anti-inflammatory ecosystem and microbiome resilience.

• These taxa were more abundant in healthy controls than in MDD patients.
• Faecalibacterium prausnitzii is a well-established anti-inflammatory commensal bacterium.
• These taxa collectively reflect what the authors term 'microbiome resilience' and an anti-inflammatory ecosystem.
• Their depletion in MDD may contribute to loss of gut barrier protection and immune dysregulation.

Functional pathway analysis in MDD indicated loss of barrier protection, antioxidants, and short-chain fatty acids, alongside activation of NIMETOX pathways.

• Functional profiling was conducted using HUMAnN v3.9, aligning microbial reads to species-specific pangenomes (Bowtie2 v2.5.4) followed by alignment to the UniRef90 v201901 protein database (DIAMOND v2.1.9).
• Pathways related to barrier protection and antioxidant production were depleted in MDD.
• Short-chain fatty acid (SCFA) production pathways were reduced in MDD patients.
• Activation of NIMETOX (neuro-immune, metabolic, and oxidative stress) pathways was detected in the MDD microbiome.

Differential abundance of gene families in MDD indicated aberrations in purine, sugar, and protein metabolism.

• Gene family profiling revealed metabolic distinctions between MDD patients and controls.
• Aberrant purine metabolism, sugar metabolism, and protein metabolism were identified in MDD-associated microbiome gene families.
• These metabolic distinctions were identified through differential abundance analysis of microbial gene families.
• UniRef90 protein database alignment was used to characterize gene families.

Gene and pathway scores explained a significant proportion of variance in suicidal ideation, recurrence of illness, neurocognitive impairments, immune functions, and atherogenicity.

• The metagenomic gene and pathway scores explained 'a larger part of the variance' in multiple clinical outcomes compared to other measures.
• Clinical outcomes significantly associated with microbiome scores included suicidal ideation, recurrence of illness, neurocognitive impairments, immune functions, and atherogenicity.
• This integrative analysis linked functional gut microbiome alterations to the clinical phenome of MDD.
• The analysis integrated metagenomic findings with immune-metabolic biomarkers of MDD.

The gut microbiome changes in MDD may contribute to activated peripheral NIMETOX pathways.

• The authors conclude that gut microbiome alterations 'might contribute to activated peripheral NIMETOX pathways in MDD.'
• This relationship is proposed to operate via leaky gut and immune-metabolic processes.
• The study design compared MDD patients versus healthy controls using shotgun metagenomics with both taxonomic and functional profiling.
• This finding supports a gut-brain axis mechanism linking microbial dysbiosis to systemic neuro-immune and metabolic dysfunction in MDD.